Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 27, 1999

View Archived Issues

Pharmacopeia to provide lead discovery services to Roche Bioscience

Abelcet approved in Belgium

Repligen receives SBIR grants to support discovery of novel active compounds

Atairgin and Northwestern University to collaborate on ovarian cancer diagnostic

Corvas enters rNAPc2 manufacturing agreement in anticipation of phase III trials

Synsorb Biotech's second quarter marked by progress in clinical trials

Alcon introduces ocular antiinflammatory agent in Germany

Hoechst Marion Roussel establishes three high-priority compounds during Q2 1999

Nabi reports positive interim results from Nabi-StaphVAX pivotal trial

Aradigm presents data on morphine electronic inhaler at pain congress in Vienna

Highly stable and lipophilic camptothecin derivatives prepared at Tigen

Ferriprox approved in Europe as second-line thalassemia therapy

The aging heart: Should we refine management?

Clinical candidate selected from 5-ht6 receptor antagonist program at Roche

ACS news flash: Agouron investigates CDK inhibitors as anticancer agents

Australian academic-industrial team identifies improved opioid analgesics

General Hospital Corp. discloses DNA vaccine for preventing, treating hepatitis C

Fujisawa prepares novel series of vasopressin antagonists

More selective GABA-A receptor ligands prepared and evaluated at Merck & Co.

University of Minnesota team describes potent and selective kappa-opioid antagonist at ACS

Institute for Diabetes Discovery researchers synthesize an improved aldose reductase inhibitor

Temodal approved in E.U. for treatment of recurrent anaplastic astrocytoma

Cell Pathways seeks approval of Aptosyn in the U.S.

ACS presentation for PD-176078, a novel calcium channel blocker with analgesic activity

Double prodrug UR-3216, a potent, long-lasting and orally active gpIIb/IIIa antagonist

SR-123781A, a novel heparin mimetic with advantages over standard heparin

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.